SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is currently trending as investors weigh significant long-term growth catalysts, including high-profile partnerships and foundry expansion, against the volatility of upcoming quarterly earnings. The community remains deeply divided, with some actively shorting the stock in anticipation of a post-earnings pullback, while others advocate for a long-term 'buy-and-hold' strategy based on the company's critical role in national infrastructure and AI chip development.

Skillz, Inc. operates a mobile gaming platform that connects players in competition. It helps developers build franchises by enabling social competition in their games. Skillz hosts casual esports tournaments for mobile players worldwide. The company was founded by Andrew C Paradise and Casey Chafkin in 2012 and is headquartered in Las Vegas, NV.

Skillz Inc - Ordinary Shares - Class A

Skillz Inc

Skillz Inc is surging after a major court victory where a jury awarded significant damages against a competitor for bot fraud, igniting intense community speculation about a potential short squeeze. Investors are aggressively debating the company's valuation and the likelihood of successful collection, while widespread frustration persists over frequent trading halts that have fueled accusations of market manipulation.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is attracting heavy attention following the official reclassification of state-licensed medical marijuana to Schedule III, a major catalyst that investors believe will alleviate significant tax burdens and improve operational viability. While the news has triggered extreme volatility and intense debate between optimistic bulls betting on a long-term sector transformation and skeptical bears wary of historic dilution and sell-the-news patterns, the community is actively tracking the stock's massive volume spikes as traders position for potential further federal policy shifts.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon shares have plummeted to multi-year lows following the announcement of a new CEO from Nike, a move that has sparked intense debate among investors wary of the hiring choice. While the community is deeply divided between those viewing the stock as a deeply undervalued fundamental play and those concerned about eroding brand relevance, active discussions remain centered on the company's lack of a clear turnaround strategy and broader retail sector weakness.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is experiencing heightened volatility and community debate as investors react to a significant equity stake disclosure from Uber, alongside ongoing concerns regarding persistent cash burn and potential dilution. While some market participants see a long-term opportunity in the firm's strategic robotaxi partnerships and Saudi PIF backing, others remain skeptical, pointing to the stock's downward trend and the looming possibility of further capital restructuring.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is trending following an earnings release where despite beating expectations, the stock faced a sharp sell-off due to margin pressure from recent acquisitions and geopolitical headwinds impacting deal flow. The community is actively debating whether this decline represents a fundamental breakdown of the SaaS business model in an AI-driven environment or a temporary valuation reset that creates a buying opportunity for long-term investors.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

The iShares Semiconductor ETF is experiencing intense volatility and heightened scrutiny as investors debate whether current price action signals a bubble or a temporary consolidation amid rapid AI-driven growth. The community remains sharply divided, with many actively trading leveraged inverse ETFs to hedge against potential downside, while others interpret the recent price swings as controlled accumulation in a sector that continues to serve as a critical proxy for overall market health.

ASGN Incorporated engages in the provision of information technology services and solutions. It operates through the Commercial and Federal Government segments. The Commercial segment involves the provision of consulting, creative digital marketing, and permanent placement services. The Federal Government segment provides mission-critical solutions. The company was founded on December 30, 1985 and is headquartered in Glen Allen, VA.

ASGN Inc

ASGN Inc. is trending as investors and social media participants debate the company's valuation and long-term outlook amidst broader concerns about demand in the IT staffing sector. The conversation is heavily polarized, featuring discussions on institutional short interest and potential manipulation, while others see value in the company's buyback authorization and market position.

8i Acquisition 2 Corp. is a blank check company. Its purpose is to enter into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The company was founded on January 21, 2021 and is headquartered in Singapore.

Euda Health Holdings Limited

Euda Health Holdings is experiencing significant volatility and momentum as traders closely monitor its low-float status and history of rapid intraday spikes. The community is actively debating the stock's potential for further gains while expressing frustration over frequent trading halts and the speculative nature of its price action.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Investors are aggressively debating the sustainability of the semiconductor rally, with many flocking to this inverse ETF in anticipation of a potential market correction. The community remains deeply divided, characterized by intense frustration over persistent semiconductor strength and speculative discussion regarding the next market catalyst.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Assembly Biosciences, Inc. (NASDAQ:ASMB) Receives Consensus Rating of "Moderate Buy" from Brokerages

Assembly Biosciences, Inc. (NASDAQ:ASMB - Get Free Report) has been assigned an average rating of "Moderate Buy" from the seven ratings firms that are presently covering the company, Marketbeat...

Assembly Biosciences (NASDAQ:ASMB) Price Target Raised to $43.00 at Guggenheim

Guggenheim raised their price objective on shares of Assembly Biosciences from $39.00 to $43.00 and gave the company a "buy" rating in a research note on Monday...

HC Wainwright Analysts Lower Earnings Estimates for ASMB

Assembly Biosciences, Inc. (NASDAQ:ASMB - Free Report) - HC Wainwright decreased their Q1 2026 earnings per share (EPS) estimates for Assembly Biosciences in a report released on Thursday, March...

Wall Street Zen Upgrades Assembly Biosciences (NASDAQ:ASMB) to Strong-Buy

Wall Street Zen upgraded shares of Assembly Biosciences from a "buy" rating to a "strong-buy" rating in a research report on Sunday...

Q1 Earnings Estimate for ASMB Issued By HC Wainwright

Assembly Biosciences, Inc. (NASDAQ:ASMB - Free Report) - Analysts at HC Wainwright issued their Q1 2027 earnings estimates for Assembly Biosciences in a report issued on Thursday, March 26th. HC Wainwright analyst P. Trucchio expects that the biopharmaceutical company will earn ($0.16) per share for...

Assembly Biosciences (NASDAQ:ASMB) Receives "Buy" Rating from HC Wainwright

HC Wainwright reaffirmed a "buy" rating and set a $50.00 price objective on shares of Assembly Biosciences in a research report on Thursday...

Assembly Biosciences (NASDAQ:ASMB) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Assembly Biosciences from a "hold" rating to a "buy" rating in a research report on Saturday...

Assembly Biosciences (NASDAQ:ASMB) Announces Quarterly Earnings Results, Beats Estimates By $2.99 EPS

Assembly Biosciences (NASDAQ:ASMB - Get Free Report) released its quarterly earnings data on Thursday. The biopharmaceutical company reported $2.48 EPS for the quarter, topping analysts' consensus estimates of ($0.51) by $2.99. The company had revenue of $42.47 million for the quarter, compared to...

Assembly Biosciences (ASMB) Q4 Earnings and Revenues Top Estimates

Assembly Biosciences (ASMB) delivered earnings and revenue surprises of +586.28% and +300.65%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Assembly Biosciences, Inc. (NASDAQ:ASMB) Given Average Recommendation of "Moderate Buy" by Analysts

Shares of Assembly Biosciences, Inc. (NASDAQ:ASMB - Get Free Report) have earned a consensus rating of "Moderate Buy" from the seven analysts that are covering the company, MarketBeat reports. One...

Assembly Biosciences, Inc. is a biotechnology company that focuses on developing small molecule antiviral therapeutics for serious viral diseases. Its lead programs, ABI-5366 and ABI-1179, long-acting helicase-primase inhibitors, are in clinical development for recurrent genital herpes. The company is partnered with Gilead Sciences to advance current and future antiviral programs across herpesviruses, HBV, and HDV. Assembly Biosciences was founded in 2005 and is headquartered in South San Francisco, CA.

ASMB
Assembly Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ASMB News

ASMBAssembly Biosciences Inc